Health Care : Current Reviews

Abstract

Depression and Anxious during COVID-19

Maya Krishnamurthy*, NC Nagalakshmi, Chaurasiya Raunakkumar and Yeshwant Kumar

According to the COVID-19 mental disorders collaborators, major depressive disorder cases worldwide increased by 276 percent and anxiety disorder cases increased by 256 percent in 2020 as a result of the pandemic. But we argue that these prevalence estimates are probably much exaggerated. Years of trauma study have demonstrated that most people have resilience (little impact on symptoms of anxiety, depression, or both) or recovery in the wake of traumatic life experiences like bereavement or catastrophe exposure (initial short-term increase in symptoms of anxiety, or depression, or both, followed by recovery). This trend is consistent with what in-depth analyses and investigations have shown about COVID-19.

Because the authors' estimations of COVID-19's impact are based solely on studies conducted predominantly during the very early phase of the pandemic, psychological model subjects are within the framework of the collaborators' study (information series for 39 of forty-eight research passed off basically among March and May 2020; appendix). The writer extrapolated from those immediate responses to determine how SARS-CoV-2 contamination costs and human mobility would affect intellectual fitness through 2020. At that time, signs and symptoms of tension or despair were at their most extreme and may have represented an acute response to a startling event.

Published Date: 2024-02-02; Received Date: 2024-01-03